Vertebral compression fracture (VCF) is a type of spinal disorder caused by the fracture of bones in the spinal cord due to osteoporosis, arthritis, and trauma. The surgical approach for the treatment of VCF includes vertebroplasty and balloon kyphoplasty. These procedures involve injecting cement in the fractured vertebral body to achieve immediate pain relief and stability.
The global VCF devices market generated $748 million in 2015, and is projected to reach $1,109 million by 2022, registering a CAGR of 5.7% from 2016 to 2022. The market is driven by factors such as increase in geriatric population, rise in incidence of osteoporosis & arthritis, and growth in patient awareness about advancements in spinal surgeries, such as artificial disc replacement. However, risk associated with post-surgical complications, i.e., hemorrhage and vertebral posterior element fracture, and stringent regulatory approval procedures are expected to hamper the market growth.
The global VCF devices market is segmented on the basis on product type, surgery, and region. Based on the type of product, the market is segmented into balloon kyphoplasty and vertebroplasty. Based on the type of surgery, the market is bifurcated into open spine surgery and minimally invasive spine surgery. The market is analyzed based on four regions, namely North America, Europe, Asia-Pacific, and LAMEA.
The key players have adopted product development strategies, including product launches, approvals, and clinical trials over the past few years. For instance, in 2014, Benvenue Medical commercially launched Kiva VCF treatment featuring a proprietary, cylindrical implant obtained from a medical polymer that provides a predictable structural support for the vertebral body, and a reservoir to contain and direct the flow of bone cement.
KEY BENEFITS FOR STAKEHOLDERS
This report offers an extensive analysis of the current trends and emerging estimations of the global VCF devices market for the period of 2014-2022 to identify the prevailing opportunities
Comprehensive analysis of all geographical regions is provided along with the factors that drive and restrict the market growth.
Quantitative analysis of the market segments is provided for the period of 2014-2022 to showcase the financial scenario.
The regional and country-level analyses of the market are provided in the report.
KEY MARKET SEGMENTS
By Product
Balloon Kyphoplasty Devices
Vertebroplasty Devices
By Surgery
Open Spine Surgery
Minimally Invasive Spine Surgery
By Region
North America
U.S.
Canada
Mexico
Europe
France
Germany
UK
Spain
Italy
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
The key companies operating in the VCF devices market that are profiled in the report are as follows:
Alphatec Holdings, Inc.
Benvenue Medical
Depuy Synthes (Johnson & Johnson)
Globus Medical, Inc.
Medtronic plc
Orthovita, Inc.
Osseon LLC
Stryker Corporation
VEXIM SA
Zimmer Biomet Holdings, Inc.
The other major players operating in this market include:
Algea Therapies
Spine Wave, Inc.
Spirit Spine
St?ckli Medical AG
